Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Breast cancer drug market set to double in 10 years

Breast cancer drug market set to double in 10 years Hospira, Puma Biotechnology, BioMarin, Syndax and Celldex.

Sanofi/Regeneron's alirocumab 'cuts cardiovascular events'

Sanofi/Regeneron's alirocumab 'cuts cardiovascular events' Sanofi and Regeneron have tried to close the gap on Amgen in the race to market by buying an FDA priority review voucher originally awarded to BioMarin Pharmaceutical.

Amgen claims first-to-file spot in PCSK9 inhibitor race

Amgen claims first-to-file spot in PCSK9 inhibitor race Giving an indication of the importance attached to reaching the market quickly, Sanofi and Regeneron recently paid $67.5m to purchase an FDA priority review voucher awarded to BioMarin Pharmaceutical by

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Sanofi and Regeneron pay $67.5m to speed alirocumab review Buy FDA priority review voucher from BioMarin.  . Sanofi and Regeneron Pharmaceuticals are paying $67.5m for an unusual licence which could enable them to get anti-cholesterol product alirocumab onto the ... We are very pleased that a patient population

AbbVie takes PARP inhibitor into third phase III trial

AbbVie takes PARP inhibitor into third phase III trial Other PARP inhibitors in clinical development include BioMarin's BMN 673 (phase III in breast cancer), Clovis Oncology's rupacarib (phase II in ovarian cancer) and Eisai's E7016 (phase II

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....

Infographics